Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study

Table 4 Assessment of individual risk factors and quality of therapeutic drug monitoring

	No need for intervention		Improvement possible		Disease untreated/ No TDM^a		No conclusion possible
	% (n)	95% CI^b	% (n)	95% CI^b	% (n)	95% CI^b	% (n)	95% CI^b
Hypertension n = 90	17.8 (16)	0.10-0.26	37.8 (34)	0.28-0.48	41.1 (37)	0.31-0.51	3.3 (3)	0.00-0.07
Diabetes mellitus n = 64	7.8 (5)	0.01-0.14	42.2 (27)	0.30-0.54	48.4 (31)	0.36-0.61	1.6 (1)	0.00-0.05
Hyperlipidemia n = 66	9.1 (6)	0.02-0.16	42.4 (28)	0.31-0.54	45.5 (30)	0.33-0.57	3.0 (2)	0.00-0.07
TDM^a n = 44	29.6 (13)	0.17-0.45	34.1 (15)	0.20-0.50	0.0 (0)	-	36.4 (16)	0.22-0.52